NeuroPace
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · California, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
455 Bernardo Ave, Mountain View, Califor...Phone Number
(650) 237-2700Website
www.neuropace.comRevenue
$99.5 MillionStock Symbol
NPCEIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
3
1
1
1
1
About NeuroPace
Founded in 1997 and headquartered in Mountain View, California, NeuroPace designs develops, manufactures, and markets implantable devices for the treatment of neurological disorders with responsive stimulation.Explore more
NeuroPace Org Chart
Get the full picture
Sign in to uncover key details.
Show More
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is NeuroPace your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at NeuroPace
Product Launch: Get notified when NeuroPace launches new products
Check if NeuroPace has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once NeuroPace has new funding data
Check out if NeuroPace is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if NeuroPace had a recent Job posting/layoffs
NeuroPace, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on NeuroPace recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined NeuroPace as Masked Content
Find more new buyers
Compare Similar Companies to NeuroPace
Compare insights from companies similar to NeuroPace, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
NeuroPace is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
NeuroPace is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about NeuroPace.
NeuroPace financials insights
Gather financial insights about NeuroPace, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2011
Private Equity
$49.1M
2013
Private Equity
$18.1M
2016
Series A
$72M
2017
Private Equity
$74M
2020
Debt
$2M
Other Financing Round
$33M
2025
Debt
$75M
NeuroPace Tech Stack
A closer look at the technologies used by NeuroPace
See more technologies
Most Recent Scoops
Open Position
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
NeuroPace has reported that its trial enrolled ahead of schedule, which the company attributes to both what clinicians were seeing in their observational work during the trial and the unmet need for this population, with people encouraged by what they were seeing and further encouraged by the data they have seen.
Medical Research, Clinical Operations
Product Launch
NeuroPace has announced a new product called Seizure ID, the company's first suite product in its artificial intelligence (AI) suite, designed to make physicians' lives easier and more efficient.
Product Launch, Doctors / Physicians, Artificial Intelligence
Project
Product Development, Medical Research
NeuroPace News & Media
NeuroPace CMO granted RSUs and stock options | NPCE Insider Trading
NeuroPace CMO Martha Morrell received 5,460 RSUs and options on 14,550 shares at $15.36, vesting from May 15, 2027 with option expiry in 2036.NeuroPace, Inc. (NPCE) Q1 2026 Earnings Call Transcript
NeuroPace, Inc. (NPCE) Q1 2026 Earnings Call May 12, 2026 4:30 PM EDTCompany ParticipantsScott Schaper - Head of Investor RelationsJoel Becker - CEO,...NeuroPace CMO reports tax-withheld shar... | NPCE Insider Trading - Stock Titan
NeuroPace CMO Martha Morrell had 1,341 shares withheld at $13.27 to cover RSU vesting taxes, retaining 47,283 shares after this routine non-market disposition.NeuroPace, Inc. (NPCE) Q4 2025 Earnings Call Transcript
NeuroPace, Inc. (NPCE) Q4 2025 Earnings Call March 3, 2026 4:30 PM ESTCompany ParticipantsScott Schaper - Head of Investor RelationsJoel Becker - CEO,...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding NeuroPace
Sign Up For FreeTo access detailed company insights
Founded in 1997 and headquartered in Mountain View, California, NeuroPace designs develops, manufactures, and markets implantable devices for the treatment of neurological disorders with responsive stimulation.... Read More
